Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 145.901% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €5.05 | €12.80 | 153.495% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €3.16 | €5.58 | 76.449% |
| Teva Pharmaceutical Industries Ltd ADR | 13 | 1 | 2 | 1 | €15.70 | €18.51 | 17.885% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.80 | €124.92 | 4.276% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €55.00 | €85.64 | 55.715% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | €64.00 | €74.65 | 16.633% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.90 | €6.45 | 240.327% |
| Bayer AG | 15 | 1 | 1 | 0 | €29.07 | €50.00 | 71.999% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €11.33 | €27.80 | 145.402% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.80 | - | - |
| Merck KGaA | 3 | 1 | 0 | 0 | €164.95 | €146.00 | -11.488% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.35 | €10.00 | 57.480% |
| Celldex Therapeutics | 10 | 1 | 1 | 0 | €37.20 | €51.25 | 37.758% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €24.40 | €60.55 | 148.172% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.60 | €50.00 | 26.263% |
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.83 | €3.03 | 65.905% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.65 | €3.70 | 124.242% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.97 | €5.51 | 469.102% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Novo Nordisk A/S ADR | 17 | 1 | 0 | 0 | €123.50 | €135.22 | 9.489% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.22 | €86.77 | 39.458% |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €23.20 | €45.21 | 94.871% |
| MacroGenics Inc. | 12 | 1 | 4 | 1 | €4.11 | €12.42 | 202.451% |